Inclusion criteria | |
1. Age > 18 years old and ≤ 80 years old | |
2. Diagnosis of hilar cholangiocarcinoma by preoperative imaging and laboratory examination; confirmed as biliary malignant tumor by intraoperative frozen and postoperative pathology; evaluated as resectable by preoperative imaging | |
3. Preoperative CT/MRI shows no obvious lymph node metastasis of groups 9, 14 and 16 | |
4. Child-Turcotte-Pugh A–B grade of liver function | |
5. Residual liver volume > 30% 6. ASA grade 1–3 | |
7. The patient has self-care ability, understands and voluntarily signs the written informed consent, and is able to complete the follow-up plan | |
8. Female patients of gestational age must be excluded from pregnancy | |
9. The patient has signed the written informed consent form before the screening test | |
Exclusion criteria | |
1. Tumor R1 resection | |
2. The patient has obvious heart, lung, brain, or kidney dysfunction that affects the treatment of cholangiocarcinoma | |
3. The patient has a history of other malignancies | |
4. Child-Turcotte-Pugh C grade of liver function | |
5. ASA grade 4–6 | |
6. Females who are pregnant or breastfeeding | |
7. Patients who are not suitable for the study as determined by the researcher |